SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-20-281266
Filing Date
2020-10-30
Accepted
2020-10-29 18:27:00
Documents
3
Group Members
MARITAL TRUST U/W/O EDWIN H WEGMAN DATED 08/10/06MARK WEGMAN

Document Format Files

Seq Description Document Type Size
1 SC 13D d70927dsc13d.htm SC 13D 82014
2 EXHIBIT 1 d70927dex991.htm EX-99.1 65635
3 EXHIBIT 2 d70927dex992.htm EX-99.2 6162
  Complete submission text file 0001193125-20-281266.txt   155108
Mailing Address 2 RIGHTER PARKWAY, SUITE 200 WILMINGTON DE 19803
Business Address 35 WILBUR ST LYNBROOK NY 11563 302-842-8450
BIOSPECIFICS TECHNOLOGIES CORP (Subject) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-79091 | Film No.: 201274037
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4092 BOCAIRE BLVD. BOCA RATON FL 33487
Business Address
Wegman Toby (Filed by) CIK: 0001405128 (see all company filings)

Type: SC 13D